ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Standard BioTools Inc

Standard BioTools Inc (LAB)

1,27
0,13
(11,40%)
Geschlossen 05 Juni 10:00PM
1,29
0,02
(1,57%)
Nach Börsenschluss: 1:40AM

Standard BioTools Inc (LAB) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
1,29
( 13,16% )
Gebot
1,28
Fragen
1,29
Volumen
3.867.451
1,135 Tagesbereich 1,29
0,8701 52-Wochen-Bereich 1,72
Marktkapitalisierung
Handelsende
1,14
Handelsbeginn
1,15
Letzte Trade
10
@
1.29
Letzter Handelszeitpunkt
Finanzvolumen
US$ 4.757.025
VWAP
1,23
Durchschnittliches Volumen (3 Mio.)
US$ 2.583.190
Ausgegebene Aktien
390.368.119
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-8,82
Gewinn pro Aktie (EPS)
0,2
Erlöse (LTM)
86,26M
Nettogewinn (LTM)
78,21M

Über Standard BioTools Inc

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operate... Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Boston, United States
Gegründet
1999
Standard BioTools Inc is listed in the Healthcare sector of the NASDAQ with ticker LAB. The last closing price for Standard BioTools was US$1,14. Over the last year, Standard BioTools shares have traded in a share price range of US$ 0,8701 to US$ 1,72.

Standard BioTools currently has 390.368.119 shares in issue. The market capitalisation of Standard BioTools is US$503,57 million. Standard BioTools has a price to earnings ratio (PE ratio) of -8.82.

LAB Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.2422.85714285711.051.291.0538108791.14900865CS
40.335135.09267986180.95491.290.950222155541.07891788CS
120.328334.13746490590.96171.290.870124514700.97218625CS
26-0.13-9.154929577461.421.720.870120493391.11327939CS
520.2220.56074766361.071.720.870118710551.1908433CS
156-1.1-46.02510460252.393.160.870116895281.68629589CS
260-4.7-78.46410684475.995.990.870111345951.71287871CS

LAB - Frequently Asked Questions (FAQ)

What is the current Standard BioTools Inc share price?
The current share price of Standard BioTools Inc is US$ 1,29
How many Standard BioTools Inc shares are in issue?
Standard BioTools Inc has 390.368.119 shares in issue
What is the market cap of Standard BioTools Inc?
The market capitalisation of Standard BioTools Inc is USD 503,57M
What is the 1 year trading range for Standard BioTools Inc share price?
Standard BioTools Inc has traded in the range of US$ 0,8701 to US$ 1,72 during the past year
What is the PE ratio of Standard BioTools Inc?
The price to earnings ratio of Standard BioTools Inc is -8,82
What is the cash to sales ratio of Standard BioTools Inc?
The cash to sales ratio of Standard BioTools Inc is 5,2
What is the registered address of Standard BioTools Inc?
The registered address for Standard BioTools Inc is 50 Milk Street, Boston, Massachusetts, 02109
What is the Standard BioTools Inc website address?
The website address for Standard BioTools Inc is www.standardbio.com
Which industry sector does Standard BioTools Inc operate in?
Standard BioTools Inc operates in the Biotechnology & Life Sciences sector

LAB Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock